QUOTE AND NEWS
FierceBiotech  Jun 6  Comment 
Eisai and Purdue Pharma have presented new clinical trial results of their dual orexin receptor antagonist lemborexant, which they think could become a new force in the sleep disorder market.
FierceBiotech  Jun 5  Comment 
While Eisai and Biogen’s oral BACE inhibitor elenbecestat was able to demonstrate a reduction in amyloid beta levels in 35 patients with Alzheimer’s disease, it failed to slow the decline of clinical symptoms more than placebo in exploratory...
FiercePharma  Jun 4  Comment 
Merck, arguably the belle of the ASCO ball, spent its on-stage time with major new data for its star drug Keytruda. But behind the scenes, it huddled up with new partners AstraZeneca and Eisai. The aim? Get the most out of the $14 billion-plus it...
FiercePharma  May 25  Comment 
Merck & Co. was expecting big things from Eisai’s Lenvima in March, when it agreed to shell out up to $5.8 billion on half of the liver cancer drug’s sales. But in the first expansion bid since that deal, Lenvima has hit a snag.
The Hindu Business Line  Apr 12  Comment 
Eisai India, a Japanese pharma company which has a unit and research centre in Visakhapatnam district, has commenced sale of Biogen’s multiple scler





You may also be interested in articles related to Eisai Co. Ltd. (ESALY):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki